nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC6A4—conduct disorder	0.464	0.566	CbGaD
Imipramine—HTR2A—conduct disorder	0.356	0.435	CbGaD
Imipramine—ORM1—saliva—conduct disorder	0.00774	0.18	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—conduct disorder	0.00594	0.138	CbGeAlD
Imipramine—HTR7—autonomic nervous system—conduct disorder	0.00573	0.133	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—conduct disorder	0.00357	0.0832	CbGeAlD
Imipramine—KCND2—brain—conduct disorder	0.0016	0.0373	CbGeAlD
Imipramine—KCND3—brain—conduct disorder	0.0014	0.0325	CbGeAlD
Imipramine—CHRM4—brain—conduct disorder	0.00133	0.031	CbGeAlD
Imipramine—HTR6—brain—conduct disorder	0.00119	0.0277	CbGeAlD
Imipramine—CHRM5—brain—conduct disorder	0.00104	0.0242	CbGeAlD
Imipramine—ADRA1B—brain—conduct disorder	0.000951	0.0221	CbGeAlD
Imipramine—ADRA1D—brain—conduct disorder	0.00093	0.0217	CbGeAlD
Imipramine—SLC22A4—brain—conduct disorder	0.000737	0.0172	CbGeAlD
Imipramine—CHRM2—brain—conduct disorder	0.000714	0.0166	CbGeAlD
Imipramine—SLC6A3—brain—conduct disorder	0.000712	0.0166	CbGeAlD
Imipramine—SLC22A1—brain—conduct disorder	0.000702	0.0163	CbGeAlD
Imipramine—HTR2C—brain—conduct disorder	0.000688	0.016	CbGeAlD
Imipramine—SLC22A3—brain—conduct disorder	0.000671	0.0156	CbGeAlD
Imipramine—SLC6A4—brain—conduct disorder	0.000653	0.0152	CbGeAlD
Imipramine—CHRM1—brain—conduct disorder	0.00065	0.0151	CbGeAlD
Imipramine—CHRM3—brain—conduct disorder	0.000582	0.0135	CbGeAlD
Imipramine—HTR1A—brain—conduct disorder	0.000579	0.0135	CbGeAlD
Imipramine—SLC6A2—brain—conduct disorder	0.000575	0.0134	CbGeAlD
Imipramine—HTR7—brain—conduct disorder	0.000554	0.0129	CbGeAlD
Imipramine—ADRA1A—brain—conduct disorder	0.000534	0.0124	CbGeAlD
Imipramine—DRD2—brain—conduct disorder	0.000524	0.0122	CbGeAlD
Imipramine—KCNH2—brain—conduct disorder	0.000516	0.012	CbGeAlD
Imipramine—Cyamemazine—HTR2A—conduct disorder	0.000471	0.0597	CrCbGaD
Imipramine—Methotrimeprazine—DRD4—conduct disorder	0.000449	0.0568	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—conduct disorder	0.000438	0.0555	CrCbGaD
Imipramine—Epinastine—HTR2A—conduct disorder	0.000435	0.0551	CrCbGaD
Imipramine—CYP2B6—brain—conduct disorder	0.000423	0.00986	CbGeAlD
Imipramine—HRH1—brain—conduct disorder	0.000413	0.00963	CbGeAlD
Imipramine—CYP2E1—brain—conduct disorder	0.000397	0.00925	CbGeAlD
Imipramine—Promazine—DRD4—conduct disorder	0.000389	0.0493	CrCbGaD
Imipramine—Maprotiline—HTR2A—conduct disorder	0.000374	0.0474	CrCbGaD
Imipramine—HTR2A—brain—conduct disorder	0.000345	0.00804	CbGeAlD
Imipramine—Chlorpromazine—DRD4—conduct disorder	0.000342	0.0433	CrCbGaD
Imipramine—Mianserin—SLC6A4—conduct disorder	0.000327	0.0415	CrCbGaD
Imipramine—CYP2D6—brain—conduct disorder	0.000315	0.00733	CbGeAlD
Imipramine—Acepromazine—HTR2A—conduct disorder	0.000303	0.0383	CrCbGaD
Imipramine—Clomipramine—SLC6A4—conduct disorder	0.000299	0.0379	CrCbGaD
Imipramine—Thioproperazine—HTR2A—conduct disorder	0.000296	0.0375	CrCbGaD
Imipramine—Nortriptyline—SLC6A4—conduct disorder	0.000293	0.0371	CrCbGaD
Imipramine—Pipotiazine—HTR2A—conduct disorder	0.000291	0.0369	CrCbGaD
Imipramine—Trimipramine—SLC6A4—conduct disorder	0.000275	0.0349	CrCbGaD
Imipramine—Doxepin—SLC6A4—conduct disorder	0.000262	0.0332	CrCbGaD
Imipramine—Mianserin—HTR2A—conduct disorder	0.000252	0.0319	CrCbGaD
Imipramine—Desipramine—SLC6A4—conduct disorder	0.000241	0.0305	CrCbGaD
Imipramine—Clomipramine—HTR2A—conduct disorder	0.00023	0.0291	CrCbGaD
Imipramine—ABCB1—brain—conduct disorder	0.000226	0.00527	CbGeAlD
Imipramine—Nortriptyline—HTR2A—conduct disorder	0.000225	0.0285	CrCbGaD
Imipramine—Trimipramine—HTR2A—conduct disorder	0.000212	0.0268	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—conduct disorder	0.000207	0.0262	CrCbGaD
Imipramine—Promethazine—HTR2A—conduct disorder	0.000204	0.0258	CrCbGaD
Imipramine—Amitriptyline—SLC6A4—conduct disorder	0.000203	0.0257	CrCbGaD
Imipramine—Doxepin—HTR2A—conduct disorder	0.000202	0.0256	CrCbGaD
Imipramine—Desipramine—HTR2A—conduct disorder	0.000185	0.0234	CrCbGaD
Imipramine—Promazine—HTR2A—conduct disorder	0.000179	0.0227	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—conduct disorder	0.000158	0.02	CrCbGaD
Imipramine—Amitriptyline—HTR2A—conduct disorder	0.000156	0.0198	CrCbGaD
Imipramine—CYP2D6—Biological oxidations—COMT—conduct disorder	8.33e-05	0.000643	CbGpPWpGaD
Imipramine—HTR7—Circadian rythm related genes—EP300—conduct disorder	8.31e-05	0.000642	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.31e-05	0.000641	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.3e-05	0.000641	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CGA—conduct disorder	8.28e-05	0.000639	CbGpPWpGaD
Imipramine—CYP2D6—Biological oxidations—MAOA—conduct disorder	8.27e-05	0.000639	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	8.26e-05	0.000637	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	8.23e-05	0.000635	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.23e-05	0.000635	CbGpPWpGaD
Imipramine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	8.22e-05	0.000634	CbGpPWpGaD
Imipramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.21e-05	0.000634	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—DRD4—conduct disorder	8.21e-05	0.000634	CbGpPWpGaD
Imipramine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.18e-05	0.000632	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	8.18e-05	0.000632	CbGpPWpGaD
Imipramine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	8.16e-05	0.00063	CbGpPWpGaD
Imipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.16e-05	0.00063	CbGpPWpGaD
Imipramine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.16e-05	0.00063	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	8.16e-05	0.00063	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	8.15e-05	0.000629	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.13e-05	0.000627	CbGpPWpGaD
Imipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.12e-05	0.000626	CbGpPWpGaD
Imipramine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.08e-05	0.000623	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	8.08e-05	0.000623	CbGpPWpGaD
Imipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.05e-05	0.000622	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.05e-05	0.000622	CbGpPWpGaD
Imipramine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	7.92e-05	0.000611	CbGpPWpGaD
Imipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.77e-05	0.0006	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.71e-05	0.000595	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CGA—conduct disorder	7.66e-05	0.000591	CbGpPWpGaD
Imipramine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	7.58e-05	0.000585	CbGpPWpGaD
Imipramine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.54e-05	0.000582	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.54e-05	0.000582	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CGA—conduct disorder	7.52e-05	0.000581	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CGA—conduct disorder	7.5e-05	0.000579	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CGA—conduct disorder	7.47e-05	0.000577	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CGA—conduct disorder	7.4e-05	0.000571	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.38e-05	0.00057	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	7.27e-05	0.000561	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	7.26e-05	0.00056	CbGpPWpGaD
Imipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.16e-05	0.000553	CbGpPWpGaD
Imipramine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.13e-05	0.00055	CbGpPWpGaD
Imipramine—CYP1A2—Biological oxidations—COMT—conduct disorder	7.06e-05	0.000545	CbGpPWpGaD
Imipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.03e-05	0.000543	CbGpPWpGaD
Imipramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.01e-05	0.000541	CbGpPWpGaD
Imipramine—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.01e-05	0.000541	CbGpPWpGaD
Imipramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.99e-05	0.000539	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CGA—conduct disorder	6.96e-05	0.000537	CbGpPWpGaD
Imipramine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	6.96e-05	0.000537	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CGA—conduct disorder	6.96e-05	0.000537	CbGpPWpGaD
Imipramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.92e-05	0.000534	CbGpPWpGaD
Imipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.9e-05	0.000533	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	6.86e-05	0.000529	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	6.71e-05	0.000518	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—DRD4—conduct disorder	6.6e-05	0.00051	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—DRD4—conduct disorder	6.59e-05	0.000509	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CGA—conduct disorder	6.57e-05	0.000507	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	6.57e-05	0.000507	CbGpPWpGaD
Imipramine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.52e-05	0.000503	CbGpPWpGaD
Imipramine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	6.4e-05	0.000494	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CGA—conduct disorder	6.29e-05	0.000486	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	6.23e-05	0.000481	CbGpPWpGaD
Imipramine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.21e-05	0.00048	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.18e-05	0.000477	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.17e-05	0.000477	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CGA—conduct disorder	6.14e-05	0.000474	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CGA—conduct disorder	6.13e-05	0.000473	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.01e-05	0.000464	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	5.96e-05	0.00046	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	5.92e-05	0.000457	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CGA—conduct disorder	5.91e-05	0.000457	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CGA—conduct disorder	5.72e-05	0.000441	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	5.61e-05	0.000433	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000431	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—WASF1—conduct disorder	5.57e-05	0.00043	CbGpPWpGaD
Imipramine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.45e-05	0.000421	CbGpPWpGaD
Imipramine—CYP3A4—Biological oxidations—COMT—conduct disorder	5.45e-05	0.000421	CbGpPWpGaD
Imipramine—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.41e-05	0.000418	CbGpPWpGaD
Imipramine—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.41e-05	0.000417	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.38e-05	0.000415	CbGpPWpGaD
Imipramine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.37e-05	0.000415	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.36e-05	0.000413	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.35e-05	0.000413	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	5.34e-05	0.000412	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	5.32e-05	0.000411	CbGpPWpGaD
Imipramine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	5.29e-05	0.000409	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CGA—conduct disorder	5.28e-05	0.000408	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	5.27e-05	0.000407	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—WASF1—conduct disorder	5.26e-05	0.000406	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.25e-05	0.000406	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CGA—conduct disorder	5.15e-05	0.000398	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CGA—conduct disorder	5.13e-05	0.000396	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.12e-05	0.000396	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.04e-05	0.000389	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CGA—conduct disorder	4.91e-05	0.000379	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.89e-05	0.000377	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.86e-05	0.000375	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000366	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	4.74e-05	0.000366	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000366	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.72e-05	0.000365	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.65e-05	0.000359	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.65e-05	0.000359	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.64e-05	0.000358	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	4.62e-05	0.000357	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	4.61e-05	0.000356	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	4.56e-05	0.000352	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.55e-05	0.000351	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CGA—conduct disorder	4.54e-05	0.000351	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CGA—conduct disorder	4.53e-05	0.000349	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	4.47e-05	0.000345	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CGA—conduct disorder	4.45e-05	0.000344	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CGA—conduct disorder	4.45e-05	0.000343	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CGA—conduct disorder	4.44e-05	0.000343	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CGA—conduct disorder	4.43e-05	0.000342	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CGA—conduct disorder	4.41e-05	0.000341	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—COMT—conduct disorder	4.41e-05	0.000341	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—MAOA—conduct disorder	4.38e-05	0.000338	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CGA—conduct disorder	4.37e-05	0.000337	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.36e-05	0.000337	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.000332	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.3e-05	0.000332	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.29e-05	0.000331	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	4.28e-05	0.000331	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.22e-05	0.000326	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.21e-05	0.000325	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.2e-05	0.000324	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.19e-05	0.000323	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—COMT—conduct disorder	4.17e-05	0.000322	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.14e-05	0.00032	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—MAOA—conduct disorder	4.14e-05	0.00032	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.13e-05	0.000319	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.13e-05	0.000319	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.11e-05	0.000317	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.06e-05	0.000314	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.03e-05	0.000311	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	3.93e-05	0.000304	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.000301	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD4—conduct disorder	3.89e-05	0.000301	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	3.89e-05	0.0003	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD4—conduct disorder	3.68e-05	0.000284	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.66e-05	0.000282	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.63e-05	0.00028	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.57e-05	0.000275	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—WASF1—conduct disorder	3.56e-05	0.000275	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—WASF1—conduct disorder	3.55e-05	0.000274	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—WASF1—conduct disorder	3.54e-05	0.000273	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD4—conduct disorder	3.52e-05	0.000272	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.51e-05	0.000271	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—WASF1—conduct disorder	3.5e-05	0.00027	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.49e-05	0.00027	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.49e-05	0.00027	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.49e-05	0.000269	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CGA—conduct disorder	3.43e-05	0.000265	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CGA—conduct disorder	3.35e-05	0.000259	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.34e-05	0.000258	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.31e-05	0.000256	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.19e-05	0.000246	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.17e-05	0.000245	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CGA—conduct disorder	3.16e-05	0.000244	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.08e-05	0.000238	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.04e-05	0.000234	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.03e-05	0.000234	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.02e-05	0.000233	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.01e-05	0.000232	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	2.98e-05	0.00023	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.97e-05	0.000229	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.89e-05	0.000223	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.87e-05	0.000222	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.8e-05	0.000216	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—COMT—conduct disorder	2.77e-05	0.000214	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—COMT—conduct disorder	2.77e-05	0.000214	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—MAOA—conduct disorder	2.75e-05	0.000213	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.75e-05	0.000212	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—MAOA—conduct disorder	2.75e-05	0.000212	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.75e-05	0.000212	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.74e-05	0.000211	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.73e-05	0.000211	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.7e-05	0.000209	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.7e-05	0.000208	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CGA—conduct disorder	2.67e-05	0.000206	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—COMT—conduct disorder	2.58e-05	0.000199	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MAOA—conduct disorder	2.56e-05	0.000198	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000196	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000196	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.53e-05	0.000196	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.49e-05	0.000192	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.49e-05	0.000192	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.48e-05	0.000191	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.47e-05	0.000191	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.45e-05	0.000189	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.44e-05	0.000188	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.4e-05	0.000185	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—COMT—conduct disorder	2.38e-05	0.000184	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MAOA—conduct disorder	2.37e-05	0.000183	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.3e-05	0.000177	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.16e-05	0.000167	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CGA—conduct disorder	2.06e-05	0.000159	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—COMT—conduct disorder	2.05e-05	0.000158	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MAOA—conduct disorder	2.04e-05	0.000157	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—COMT—conduct disorder	2.01e-05	0.000155	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MAOA—conduct disorder	1.99e-05	0.000154	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—EP300—conduct disorder	1.89e-05	0.000146	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000145	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.87e-05	0.000145	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.79e-05	0.000138	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—EP300—conduct disorder	1.79e-05	0.000138	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.65e-05	0.000128	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.62e-05	0.000125	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.62e-05	0.000125	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.61e-05	0.000125	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.6e-05	0.000123	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.59e-05	0.000123	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—COMT—conduct disorder	1.55e-05	0.00012	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MAOA—conduct disorder	1.54e-05	0.000119	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—COMT—conduct disorder	1.51e-05	0.000117	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MAOA—conduct disorder	1.5e-05	0.000116	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.49e-05	0.000115	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—COMT—conduct disorder	1.43e-05	0.00011	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MAOA—conduct disorder	1.41e-05	0.000109	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EP300—conduct disorder	1.27e-05	9.82e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EP300—conduct disorder	1.22e-05	9.4e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—COMT—conduct disorder	1.21e-05	9.32e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MAOA—conduct disorder	1.2e-05	9.25e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—EP300—conduct disorder	1.19e-05	9.18e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—EP300—conduct disorder	1.19e-05	9.16e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.16e-05	8.97e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.14e-05	8.84e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—EP300—conduct disorder	1.11e-05	8.54e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—EP300—conduct disorder	1.02e-05	7.89e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EP300—conduct disorder	9.98e-06	7.7e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EP300—conduct disorder	9.93e-06	7.66e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EP300—conduct disorder	9.5e-06	7.33e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—COMT—conduct disorder	9.32e-06	7.19e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MAOA—conduct disorder	9.25e-06	7.14e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—EP300—conduct disorder	8.79e-06	6.79e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EP300—conduct disorder	8.76e-06	6.76e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EP300—conduct disorder	8.62e-06	6.65e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—EP300—conduct disorder	8.61e-06	6.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EP300—conduct disorder	8.6e-06	6.64e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EP300—conduct disorder	8.57e-06	6.62e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EP300—conduct disorder	8.55e-06	6.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EP300—conduct disorder	8.46e-06	6.53e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.44e-06	6.52e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—EP300—conduct disorder	6.64e-06	5.13e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—EP300—conduct disorder	6.48e-06	5.01e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—EP300—conduct disorder	6.11e-06	4.72e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—EP300—conduct disorder	5.18e-06	4e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—EP300—conduct disorder	4e-06	3.08e-05	CbGpPWpGaD
